Abbott and Alere Deal Expected to Close; Maintaining FVE
No-moat Alere recently put out anemic first- and second-quarter financial results, and we are maintaining our $51 per share fair value estimate due to the pending acquisition by Abbott Laboratories. We expect Abbott’s $5.3 billion acquisition of Alere, a reduction from the original purchase price of $5.8 billion, to close in the coming months. From the initial announcement of the purchase, the acquisition process has been somewhat tumultuous, as Alere was plagued by financial filing delays, with...
Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.
Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.
We have operations in 27 countries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.